Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bursen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Oncogene|November 30, 2006
Combined effects of the two reciprocal t(4;11) fusion proteins MLL.AF4 and AF4.MLL confer resistance to apoptosis, cell cycling capacity and growth transformationA Gaussmann, T Wenger, I Eberle, et al.
Oncogene|September 20, 2006
Transcription linked to recombination: a gene-internal promoter coincides with the recombination hot spot II of the human MLL geneS Scharf, J Zech, A Bursen, et al.
Leukemia|October 30, 2010
The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signaturesA Benedikt, S Baltruschat, B Scholz, et al.
Leukemia|November 19, 2013
Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize/transform cord blood CD34+ cellsR Montes, V Ayllón, C Prieto, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Oncogene|November 30, 2006
Combined effects of the two reciprocal t(4;11) fusion proteins MLL.AF4 and AF4.MLL confer resistance to apoptosis, cell cycling capacity and growth transformationA Gaussmann, T Wenger, I Eberle, et al.
Oncogene|September 20, 2006
Transcription linked to recombination: a gene-internal promoter coincides with the recombination hot spot II of the human MLL geneS Scharf, J Zech, A Bursen, et al.
Leukemia|October 30, 2010
The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signaturesA Benedikt, S Baltruschat, B Scholz, et al.
Leukemia|November 19, 2013
Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize/transform cord blood CD34+ cellsR Montes, V Ayllón, C Prieto, et al.
Pageof 1